Chemours
485 hedge funds and large institutions have $2.72B invested in Chemours in 2022 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 161 increasing their positions, 152 reducing their positions, and 68 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
485
Holders Change
-30
Holders Change %
-5.83%
% of All Funds
8.39%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.1%
New
47
Increased
161
Reduced
152
Closed
68
Calls
$45M
Puts
$71.7M
Net Calls
-$26.8M
Net Calls Change
+$28.6M
Top Buyers
| 1 |
Amundi
Paris,
France
|
+$24.7M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$23.3M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$23M |
| 4 |
JPMorgan Chase & Co
New York
|
+$16.1M |
| 5 |
AWAM
Appian Way Asset Management
New York
|
+$15.4M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$64.9M |
| 2 |
SC
Sessa Capital
New York
|
-$54.4M |
| 3 |
GC
Greenlight Capital
New York
|
-$22.4M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$21.1M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$17M |
